Document Detail

Rocuronium and sugammadex used effectively for electroconvulsive therapy in a patient with brugada syndrome.
MedLine Citation:
PMID:  22622300     Owner:  NLM     Status:  In-Data-Review    
ABSTRACT: We report the successful anesthetic management of a patient with Brugada syndrome who underwent electroconvulsive therapy to treat bipolar disorder. Suxamethonium and neostigmine were contraindicated to avoid the vagotonic effects that can precipitate ventricular fibrillation during anesthesia in patients with Brugada syndrome. The combination of 1.2 mg/kg rocuronium and 10 mg/kg sugammadex was effectively and safely used to induce and antagonize neuromuscular block for 8 consecutive electroconvulsive therapy sessions in this patient.
Junpei Konishi; Takahiro Suzuki; Yuko Kondo; Miyako Baba; Setsuro Ogawa
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of ECT     Volume:  28     ISSN:  1533-4112     ISO Abbreviation:  J ECT     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9808943     Medline TA:  J ECT     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e21-2     Citation Subset:  IM    
From the Department of Anesthesiology, Nihon University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electroconvulsive therapy in the presence of atrial septal defect: a case report.
Next Document:  Effects on intracranial pressure of electroconvulsive therapy.